About
About Bioheng
History
Science & Products
Pipelines
Technology Platforms
Publications
Patients
Expanded access
News
Event Highlights
Contact
Investor Relations&BD
07
2025-11
Expanded access policy
At Imviva Biotech we are committed to developing innovative, cell-based therapies for patients with serious or life-threatening diseases, especially where existing treatment options are limited or ineffective.
Contact Us
Consult Now